Company Filing History:
Years Active: 1996-2001
Title: Alan Frey: Innovator in Lyme Disease Vaccine Development
Introduction
Alan Frey is a notable inventor based in Highland Park, NJ (US). He has made significant contributions to the field of vaccine development, particularly in the fight against Lyme Disease. With a total of 2 patents, Frey has focused on creating effective solutions to combat this prevalent illness.
Latest Patents
Frey's latest patents include the "Production of Borrelia Burgdorferi Vaccine, Product Produced Thereby and Method of Use." This patent describes a process for preparing a vaccine from substantially viable spirochetal bacteria of Borrelia. The vaccine is designed to induce an immune or therapeutic response against Lyme Disease when administered to a patient. The method involves ultrasound treatment of the bacteria, resulting in a product that can be used for immunization and therapy to minimize or prevent the contraction of the disease. Another significant patent is the "Sonicated Borrelia Burgdorferi Vaccine," which follows a similar process and aims to provide effective treatment options for patients suffering from Lyme Disease.
Career Highlights
Alan Frey is currently associated with Rx Technologies, where he continues to innovate in the field of medical research and vaccine development. His work has been instrumental in advancing the understanding and treatment of Lyme Disease.
Collaborations
Frey collaborates with Howard M Alliger, contributing to the development of groundbreaking medical solutions.
Conclusion
Alan Frey's contributions to vaccine development, particularly for Lyme Disease, highlight his commitment to improving public health through innovation. His patents represent significant advancements in the field, showcasing the potential for effective treatments against this challenging disease.